Mostrar el registro sencillo del ítem
Manejo de tetralogía de fallot fetal en embarazo a termino.
| dc.contributor.advisor | Ordóñez Sánchez, Joe Luis | |
| dc.contributor.author | Lara Rojas, Itsa Beatriz | |
| dc.date.accessioned | 2020-09-29T16:14:52Z | |
| dc.date.available | 2020-09-29T16:14:52Z | |
| dc.date.issued | 2020 | |
| dc.identifier.uri | http://dspace.utb.edu.ec/handle/49000/8393 | |
| dc.description | Nowadays, hearing people say "Science has advanced a lot" makes me think of all the guides and methods for both diagnosis and management of different existing pathologies, without a doubt there are many but it is also true that they represent only a grain of sand in the sea, so to speak. Among the existing congenital heart diseases described in different medical articles, they coincide in that 1/1000 live births develop Tetralogy of Fallot, four congenital anomalies that characterize a disease: ventricular septal defect, right ventricular outlet obstruction, right ventricular hypertrophy, and tripping of the aorta. Among its symptoms, cyanosis and other symptoms stand out. Adequate preconception control allows us to expand our knowledge about the development of pregnancy by identifying whether or not there is something out of the ordinary; It is expected that every pregnant woman complies with each control, obtaining a healthy term product but when a patient goes to the emergency room for signs and symptoms previously treated in primary care centers, and in addition, the decision is made to enter her for greater surveillance of their general condition, for me, is an indication that something was overlooked, that this protocol suggested as adequate pregnancy care may not be adapted for the diagnosis of diseases such as the one mentioned above, and that today there are more and more common. Should we wait for the product to be born and show symptoms to be able to do something? ¿Can the quality of the product be improved intrauterine once it is diagnosed in time?. In the following clinical case, a pregnant woman without precedent or relevant maternal-fetal symptoms that would lead to the diagnosis of intrauterine tetralogy of fallot was analyzed, so when obtaining a live product, of weight and gestational age in normal parameters, it begins to develop in few hours symptoms of this heart disease. The decisions that were made, having knowledge of when and to what extent the health personnel could act, have so far allowed one of the authors of this presentation to be kept alive, described in detail below. | es_ES |
| dc.description | Nowadays, hearing people say "Science has advanced a lot" makes me think of all the guides and methods for both diagnosis and management of different existing pathologies, without a doubt there are many but it is also true that they represent only a grain of sand in the sea, so to speak. Among the existing congenital heart diseases described in different medical articles, they coincide in that 1/1000 live births develop Tetralogy of Fallot, four congenital anomalies that characterize a disease: ventricular septal defect, right ventricular outlet obstruction, right ventricular hypertrophy, and tripping of the aorta. Among its symptoms, cyanosis and other symptoms stand out. Adequate preconception control allows us to expand our knowledge about the development of pregnancy by identifying whether or not there is something out of the ordinary; It is expected that every pregnant woman complies with each control, obtaining a healthy term product but when a patient goes to the emergency room for signs and symptoms previously treated in primary care centers, and in addition, the decision is made to enter her for greater surveillance of their general condition, for me, is an indication that something was overlooked, that this protocol suggested as adequate pregnancy care may not be adapted for the diagnosis of diseases such as the one mentioned above, and that today there are more and more common. Should we wait for the product to be born and show symptoms to be able to do something? ¿Can the quality of the product be improved intrauterine once it is diagnosed in time?. In the following clinical case, a pregnant woman without precedent or relevant maternal-fetal symptoms that would lead to the diagnosis of intrauterine tetralogy of fallot was analyzed, so when obtaining a live product, of weight and gestational age in normal parameters, it begins to develop in few hours symptoms of this heart disease. The decisions that were made, having knowledge of when and to what extent the health personnel could act, have so far allowed one of the authors of this presentation to be kept alive, described in detail below. | es_ES |
| dc.description.abstract | En la actualidad escuchar decir “La ciencia ha avanzado mucho” me hace pensar en todos las guías y métodos tanto de diagnóstico como de manejo de diferentes patologías existentes, sin duda alguna son muchas pero también es cierto que representan solo un grano de arena en el mar, por así decirlo. Dentro de las cardiopatías congénitas existentes descritas en diferentes artículos médicos, estas coinciden en que 1/1000 nacidos vivos desarrolla Tetralogía de Fallot, cuatro anomalías congénitas que caracterizan una enfermedad: comunicación interventricular, obstrucción a la salida del ventrículo derecho, hipertrofia ventricular derecha y acabalgamiento de la aorta. Dentro de su sintomatología se destaca la cianosis y otros síntomas. El adecuado control preconcepcional nos permite ampliar nuestro conocimiento sobre el desarrollo del embarazo identificando si hay o no algo fuera de lo normal; se espera que toda gestante cumpla con cada control, obteniendo un producto a término saludable pero cuando una paciente acude a emergencias por signos y síntomas previamente tratados en centros de atención primaria, y además de ello se toma la decisión de ingresarla para una mayor vigilancia de su estado general, para mí es un indicativo de que algo se pasó por alto, de que este protocolo sugerido como adecuado cuidado del embarazo puede no estar adaptado para el diagnóstico de enfermedades como la antes mencionada, y que hoy en dia son cada vez más comunes. ¿Se debe acaso esperar que el producto nazca y presente síntomas para poder hacer algo? o ¿Se puede mejor la calidad del producto de forma intraútero una vez se halla diagnosticado a tiempo?. En el siguiente caso clínico se analizara a una gestante sin precedente o sintomatología materno-fetal relevantes que conducirían a diagnosticar una tetralogía de fallot intraútero, por lo que al obtener un producto vivo, de peso y edad gestacional en parámetros normales este empieza a desarrolla en pocas horas sintomatología propia de esta cardiopatía. Las decisiones que se tomaron, teniendo conocimientos de cuándo y hasta donde podía actuar al personal de salud han permitido hasta ahora mantener con vida a una de las autoras de esta presentación, descrita detalladamente a continuación. | es_ES |
| dc.format.extent | 38 p. | es_ES |
| dc.language.iso | es | es_ES |
| dc.publisher | Babahoyo: UTB-FCS, 2020 | es_ES |
| dc.rights | Atribución-NoComercial-SinDerivadas 3.0 Ecuador | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/ec/ | * |
| dc.subject | Tetralogía | es_ES |
| dc.subject | Fallot | es_ES |
| dc.subject | Cianosis | es_ES |
| dc.subject | Hipertrofia | es_ES |
| dc.subject | Ventrículo | es_ES |
| dc.subject | Preconcepcional | es_ES |
| dc.title | Manejo de tetralogía de fallot fetal en embarazo a termino. | es_ES |
| dc.type | bachelorThesis | es_ES |
Ficheros en el ítem
Este ítem aparece en la(s) siguiente(s) colección(ones)
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución-NoComercial-SinDerivadas 3.0 Ecuador